Quest Diagnostics Finalizes $500M Senior Notes Offering Due 2036

summarizeSummary

Quest Diagnostics has finalized the terms for a $500 million offering of 5.000% Senior Notes due 2036, with proceeds intended for general corporate purposes including debt repayment.

check_boxKey Events

• Finalized Debt Offering

  Quest Diagnostics finalized the terms for a $500 million offering of 5.000% Senior Notes due 2036.

• Maturity and Yield

  The notes have a maturity date of June 30, 2036, and an issue price of 98.751% of the principal amount, resulting in a yield of 5.158%.

• Use of Proceeds

  Proceeds are designated for general corporate purposes, including the repayment of existing indebtedness, specifically mentioning the 3.45% Senior Notes due June 1, 2026.

• Credit Ratings

  The notes carry investment-grade ratings of Baa1 (Moody's), BBB+ (S&P), and BBB+ (Fitch).

auto_awesomeAnalysis

This Free Writing Prospectus (FWP) finalizes the terms of Quest Diagnostics' $500 million senior notes offering, initiated via a prior registration statement. The issuance of 5.000% notes maturing in 2036 is a significant financing event, representing a strategic move to manage the company's capital structure. The proceeds are earmarked for general corporate purposes, including the refinancing of existing indebtedness, such as the 3.45% Senior Notes due in June 2026. This proactive debt management, coupled with the company's recent strong financial performance and ongoing share repurchase program, indicates a stable financial position and prudent capital allocation.